Kevin Parker

Founder & CEO

Holds a BA in Human Developmental and Regenerative Biology from Harvard and a PhD from Stanford, studying at the intersection of genomics, immunology, and computational biology. Named to Endpoints News' 20 Under 40 list.

Overview

Companies
1
Roles
Founder & CEO

Companies

1 company
Cartography Biosciences $124M
Private Founder & CEO

Cartography Biosciences is a precision oncology company developing cancer immunotherapies guided by the first comprehensive antigen atlas for immuno-oncology targets. The company's proprietary ATLAS and SUMMIT platforms combine single-cell genomics, proteomics, and computational biology to identify tumor-selective antigens, enabling antibody-based therapies that target tumors more precisely than existing therapeutics.

Founder data is compiled from company records, public announcements, and verified sources. Roles reflect current or most recent known positions.